Thank you letter
Release time:
2020-07-22
Editor's Note: In April this year, 4 employees from the marketing department of Guizhou Huangping Jianfeng Cement Company went to Daye Jianfeng Cement Company to study for one month. After the study, they wrote this thank-you letter, thanking the colleagues in Daye Peak Marketing Department for their careful guidance and care.
4 internship team successfully completed this internship with the help and guidance of the leaders and teachers of Daye Jianfeng Marketing Department. At the end of our study life, we would like to express our heartfelt thanks and highest respect to the leaders of your company and the teachers!
April 13 , we came to daye peak with hope and expectation and started our internal work internship in the marketing department. During the internship, the teachers were tolerant and taught us. They had many small details that made us feel very much. For example, in the acceptance ratio table, many data sources were different. The teachers were afraid that we could not remember or mix them up. They also specially marked the sources of the data and which were made by ourselves. These small actions of the masters are like the big sister at home patiently guiding us, making us feel the warmth of our relatives. It is getting closer and closer to our return to Guizhou, and we are all very happy. Unexpectedly, on August 28, 2008, Chen Xiaomin and Zhang Xinmei had a little problem and had a high fever. The company sent a special car to the hospital. During their illness, the teachers and leaders were very concerned about our safety. Everyone sent us greetings like relatives. It was really warm and made us feel that the company was a big family, I really appreciate the concern of teachers and leaders. Now we are about to return to Guizhou Peak, and we have too much reluctance and nostalgia in our hearts. We have thousands of words in our hearts, but what we want to say most is "thank you "
Here we sincerely invite the leaders and teachers of Daye Peak Marketing Department to come to Guizhou to have time to see the green mountains and rivers of Guizhou and experience our different ethnic customs. Finally, I wish Daye Peak a prosperous career! I wish the leaders and teachers of the marketing department good health, smooth work and full of peaches and plums!
Guizhou Peak Marketing Department
Dragon Orchid
Zhang Xinmei
Chen Xiaomin
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31